Schmitt A - Search Results

1

Improving olaparib exposure to optimize adverse effects management.

Sterlé M, Puszkiel A, Burlot C, Pereira E, Bellesoeur A, De Percin S, Beinse G, Fumet JD, Favier L, Niogret J, Blanchet B, Royer B, Bengrine-Lefevre L, Schmitt A. Sterlé M, et al. Among authors: schmitt a. Ther Adv Med Oncol. 2024 Apr 24;16:17588359241248328. doi: 10.1177/17588359241248328. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38665845 Free PMC article.

2

5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.

Morawska K, Goirand F, Marceau L, Devaux M, Cueff A, Bertaut A, Vincent J, Bengrine-Lefevre L, Ghiringhelli F, Schmitt A. Morawska K, et al. Among authors: schmitt a. Oncotarget. 2018 Jan 30;9(14):11559-11571. doi: 10.18632/oncotarget.24338. eCollection 2018 Feb 20. Oncotarget. 2018. PMID: 29545919 Free PMC article.

3

Retrospective evaluation of FOLFIRI3 alone or in combination with bevacizumab or aflibercept in metastatic colorectal cancer.

Devaux M, Gerard L, Richard C, Bengrine-Lefevre L, Vincent J, Schmitt A, Ghiringhelli F. Devaux M, et al. Among authors: schmitt a. World J Clin Oncol. 2019 Feb 24;10(2):75-85. doi: 10.5306/wjco.v10.i2.75. World J Clin Oncol. 2019. PMID: 30815374 Free PMC article.

4

Therapeutic drug monitoring as a tool to optimize 5-FU-based chemotherapy in gastrointestinal cancer patients older than 75 years.

Macaire P, Morawska K, Vincent J, Quipourt V, Marilier S, Ghiringhelli F, Bengrine-Lefevre L, Schmitt A. Macaire P, et al. Among authors: schmitt a. Eur J Cancer. 2019 Apr;111:116-125. doi: 10.1016/j.ejca.2019.01.102. Epub 2019 Mar 5. Eur J Cancer. 2019. PMID: 30849685

5

A simple and fast LC-MS/MS method for the routine measurement of cabozantinib, olaparib, palbociclib, pazopanib, sorafenib, sunitinib and its main active metabolite in human plasma.

Jolibois J, Schmitt A, Royer B. Jolibois J, et al. Among authors: schmitt a. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Nov 15;1132:121844. doi: 10.1016/j.jchromb.2019.121844. Epub 2019 Oct 21. J Chromatogr B Analyt Technol Biomed Life Sci. 2019. PMID: 31678788

6

Impact of granulocyte colony-stimulating factor on FOLFIRINOX-induced neutropenia prevention: A population pharmacokinetic/pharmacodynamic approach.

Macaire P, Paris J, Vincent J, Ghiringhelli F, Bengrine-Lefevre L, Schmitt A. Macaire P, et al. Among authors: schmitt a. Br J Clin Pharmacol. 2020 Dec;86(12):2473-2485. doi: 10.1111/bcp.14356. Epub 2020 Jun 5. Br J Clin Pharmacol. 2020. PMID: 32386071 Free PMC article.

7

Exposure-response analysis of Raltitrexed assessing liver toxicity.

Royer B, Schmitt A, Nguyen T, Paillard MJ, Jary M, Demarchi M, Vernerey D, Henriques J, Jacquin M, Borg C, Kim S. Royer B, et al. Among authors: schmitt a. Br J Clin Pharmacol. 2021 Mar;87(3):1327-1337. doi: 10.1111/bcp.14519. Epub 2020 Sep 4. Br J Clin Pharmacol. 2021. PMID: 32789966 Free article. Clinical Trial.

8

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure.

Dolat M, Macaire P, Goirand F, Vincent J, Hennequin A, Palmier R, Bengrine-Lefevre L, Ghiringhelli F, Royer B, Schmitt A. Dolat M, et al. Among authors: schmitt a. Pharmaceuticals (Basel). 2020 Nov 23;13(11):416. doi: 10.3390/ph13110416. Pharmaceuticals (Basel). 2020. PMID: 33238487 Free PMC article.

9

Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients.

Lunar N, Etienne-Grimaldi MC, Macaire P, Thomas F, Dalenc F, Ferrero JM, Pivot X, Milano G, Royer B, Schmitt A. Lunar N, et al. Among authors: schmitt a. Cancer Chemother Pharmacol. 2021 Feb;87(2):229-239. doi: 10.1007/s00280-020-04208-8. Epub 2021 Jan 2. Cancer Chemother Pharmacol. 2021. PMID: 33386926

10

Artificial increase of uracilemia during fluoropyrimidine treatment can lead to DPD deficiency misinterpretation.

Thomas F, Maillard M, Launay M, Tron C, Etienne-Grimaldi MC, Gautier-Veyret E, Haufroid V, Pallet N, Royer B, Narjoz C, Schmitt A; Groupe de Pharmacologie Clinique Oncologique (GPCO-UNICANCER). Thomas F, et al. Among authors: schmitt a. Ann Oncol. 2021 Jun;32(6):810-811. doi: 10.1016/j.annonc.2021.02.020. Epub 2021 Mar 1. Ann Oncol. 2021. PMID: 33662499 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,875 results

Search Page

Filters